Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Extracellular cleavage of the p75 neurotrophin receptor is implicated in its pro‐survival effect in breast cancer cells

View through CrossRef
The p75 neurotrophin receptor (p75NTR) undergoes sequential proteolytic cleavages leading to the generation of a carboxyl‐terminal fragment (p75NTR‐CTF) and an intracellular domain (p75NTR‐ICD) in many cellular models. We have previously shown that p75NTR is involved in the survival of breast cancer cells. Here, we demonstrated that p75NTR cleavage occurs also in these cells. Surprisingly, p75NTR‐CTF increased cell survival, whereas p75NTR‐ICD had no effect. The pro‐survival effect of p75NTR‐CTF was associated with a decrease of TNF‐related apoptosis‐inducing ligand (TRAIL)‐induced PARP and caspase 3 cleavages. Finally, our findings indicate that p75NTR could favor cell survival via its carboxyl‐terminal fragment, independently of PI3‐kinase, NF‐κB, or MAP kinase signaling pathways.
Title: Extracellular cleavage of the p75 neurotrophin receptor is implicated in its pro‐survival effect in breast cancer cells
Description:
The p75 neurotrophin receptor (p75NTR) undergoes sequential proteolytic cleavages leading to the generation of a carboxyl‐terminal fragment (p75NTR‐CTF) and an intracellular domain (p75NTR‐ICD) in many cellular models.
We have previously shown that p75NTR is involved in the survival of breast cancer cells.
Here, we demonstrated that p75NTR cleavage occurs also in these cells.
Surprisingly, p75NTR‐CTF increased cell survival, whereas p75NTR‐ICD had no effect.
The pro‐survival effect of p75NTR‐CTF was associated with a decrease of TNF‐related apoptosis‐inducing ligand (TRAIL)‐induced PARP and caspase 3 cleavages.
Finally, our findings indicate that p75NTR could favor cell survival via its carboxyl‐terminal fragment, independently of PI3‐kinase, NF‐κB, or MAP kinase signaling pathways.

Related Results

Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor
Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor
Abstract TU27, a mouse IgG1 mAb directed at the p75 chain of the human IL-2R, was analyzed for its ability to interact with IL-2 binding on isolated p75 chains (YT-2...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Effect of type lll collagen coating of electrospun scaffolds on breast cancer cell apoptosis
Effect of type lll collagen coating of electrospun scaffolds on breast cancer cell apoptosis
Breast cancer arises from the epithelial or the connective tissue components of the breast. Breast cancer is the most commonly diagnosed cancer in women, with about half a million ...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...

Back to Top